Bicalutamide (CDX) by MilliporeSigma

Manufacturer MilliporeSigma

Bicalutamide (CDX) by MilliporeSigma product image
Bicalutamide (CDX)

0 Scientists have reviewed this product

Write the First Review

No Reviews

Bicalutamide (CDX) is a non-steriodal Androgen Receptor (AR) antagonist and a pure antiandrogen. It acts via balancing histone acetylation/deacetylation and recruitment of coregulators. Bicalutamide (CDX) abolishes androgen-mediated expression. For example, MMP13 upregulation in prostate cancer, PLZF (promyelocytic leukemia zinc finger protein), and GADD45γ (growth arrest and DNA damage inducible, gamma). Bicalutamide (CDX) is inhibited by non-genomic, transcription-independent stimulation of PI3K/AKT phosphorylation by androgens.